Hims & Hers Health, Inc. (HIMS) Q2 2023 Earnings Results

HIMS & HERS HEALTH I Class A Beats on EPS, Stock Down 3.07%

HIMS & HERS reported a narrower-than-expected loss per share, which may indicate improved operational efficiency. However, the stock fell by 3.07%, likely reflecting investor concerns about the lack of revenue details and forward guidance. The market may be cautious as the company navigates a competitive retail environment.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.03	N/A	+48.28%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management remains focused on expanding their customer base and improving retention rates. They acknowledged the competitive landscape but are optimistic about their strategic direction.

Management highlighted the importance of focusing on customer growth and retention.

They expressed confidence in their long-term strategy despite current challenges.

HIMS & HERS HEALTH I Class A Beats on EPS, Stock Down 3.07%

Key numbers

Management commentary

Hims & Hers Health, Inc.

More earnings this week

HIMS & HERS HEALTH I Class A Beats on EPS, Stock Down 3.07%

Key numbers

Management commentary